Activation of invariant Natural Killer T lymphocytes in response to the α-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles

International Journal of Pharmaceutics

Volumn 423, Issue 1, 2012, Pages 45-54

  MacHo Fernandez, Elodie ^a,b,c,d,e   Chang, Jiang ^b,f   Fontaine, Josette ^a,b,c,d,e   Bialecki, Emilie ^a,b,c,d,e   Rodriguez, Fabien ^a,b,c,d,e   Werkmeister, Elisabeth ^e,h   Krieger, Vanessa ^h   Ehret, Christophe ⁱ   Heurtault, Béatrice ⁱ   Fournel, Sylvie ^h   Frisch, Benoit ⁱ   Betbeder, Didier ^b,f,g   Faveeuw, Christelle ^a,b,c,d,e   Trottein, Franois ^a,b,c,d,e  

^a INSTITUT PASTEUR DE LILLE   (France)

^b UNIV LILLE   (France)

^c INSERM U1019   (France)

^d INSERM   (France)

^e Institut Federatif de Recherche 142   (France)

^f France Institut Pasteur de Lille   (France)

^g UNIVERSITÉ D'ARTOIS   (France)

^h CNRS   (France)

ⁱ UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Cytokines; Dendritic cells; iNKT cells; KRN; PLGA based particles

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; ALPHA GALACTOSYLCERAMIDE; CLATHRIN; NANOPARTICLE; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CELL EXPANSION; CONFERENCE PAPER; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; DRUG RECALL; EFFECTOR CELL; ENDOCYTOSIS; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE MICROPARTICLE; MALE; MICROENCAPSULATION; MOUSE; NANOENCAPSULATION; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN PRESENTATION; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CLATHRIN; COCULTURE TECHNIQUES; DENDRITIC CELLS; DRUG CARRIERS; ENDOCYTOSIS; GALACTOSYLCERAMIDES; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-4; KILLER CELLS, NATURAL; LACTIC ACID; LEUKOCYTES, MONONUCLEAR; LIVER; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSPHERES; NANOPARTICLES; NATURAL KILLER T-CELLS; PARTICLE SIZE; POLYGLYCOLIC ACID; SPLEEN; STATIC ELECTRICITY; SURFACE PROPERTIES;

EID: 84855761355     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.04.068     Document Type: Conference Paper

References (58)

1. H. Azuma, S. Tamagaki, and K. Ogino Stereospecific total syntheses of sphingosine and its analogues from l-serine J. Org. Chem. 65 2000 3538 3541 (Pubitemid 30346814)
2. J.M. Barichello, M. Morishita, K. Takayama, and T. Nagai Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method Drug Dev. Indus. Pharm. 25 1999 471 476 (Pubitemid 29159426)
3. A. Bendelac, P.B. Savage, and L. Teyton The biology of NKT cells Annu. Rev. Immunol. 25 2007 297 336 (Pubitemid 46697911)
4. A.C. Benoit, Y. Huang, S. Maneewatchararangsri, P. Tapchaisri, and R. Anderson Regulation of airway eosinophil and neutrophil infiltration by alpha-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease Vaccine 25 2007 7754 7762 (Pubitemid 47588530)
5. J.S. Bezbradica, A.K. Stanic, N. Matsuki, H. Bour-Jordan, J.A. Bluestone, J.W. Thomas, D. Unutmaz, L. Van Kaer, and S. Joyce Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo J. Immunol. 174 2005 4696 4705
6. V. Cerundolo, J.D. Silk, S.H. Masri, and M. Salio Harnessing invariant NKT cells in vaccination strategies Nat. Rev. Immunol. 9 2009 28 38
7. D.H. Chang, K. Osman, J. Connolly, A. Kukreja, J. Krasovsky, M. Pack, A. Hutchinson, M. Geller, N. Liu, and R. Annable Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients J. Exp. Med. 201 2005 1503 1517 (Pubitemid 40664093)
8. N.R. Cohen, S. Garg, and M.B. Brenner Antigen presentation by CD1 lipids, T cells, and NKT cells in microbial immunity Adv. Immunol. 102 2009 1 94
9. N.Y. Crowe, A.P. Uldrich, K. Kyparissoudis, K.J. Hammond, Y. Hayakawa, S. Sidobre, R. Keating, M. Kronenberg, M.J. Smyth, and D.I. Godfrey Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells J. Immunol. 171 2003 4020 4027 (Pubitemid 37238677)
10. L.J. Cruz, P.J. Tacken, R. Fokkink, B. Joosten, M.C. Stuart, F. Albericio, R. Torensma, and C.G. Figdor Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro J. Control. Release 144 2010 118 126
11. O. Dechy-Cabaret, B. Martin-Vaca, and D. Bourissou Controlled ring-opening polymerization of lactide and glycolide Chem. Rev. 104 2004 6147 6176 (Pubitemid 40025736)
12. M.V. Dhodapkar, M.D. Geller, D.H. Chang, K. Shimizu, S. Fujii, K.M. Dhodapkar, and J. Krasovsky A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma J. Exp. Med. 197 2003 1667 1676 (Pubitemid 36745342)
13. J.H. Eldridge, J.K. Staas, J.A. Meulbroek, T.R. Tice, and R.M. Gilley Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies Infect. Immun. 59 1991 2978 2986
14. T.M. Fahmy, S.L. Demento, M.J. Caplan, I. Mellman, and W.M. Saltzman Design opportunities for actively targeted nanoparticle vaccines Nanomedicine (London, England) 3 2008 343 355 (Pubitemid 351827311)
15. T. Fifis, A. Gamvrellis, B. Crimeen-Irwin, G.A. Pietersz, J. Li, P.L. Mottram, I.F. McKenzie, and M. Plebanski Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors J. Immunol. 173 2004 3148 3154 (Pubitemid 39142021)
16. S. Fujii, K. Shimizu, H. Hemmi, and R.M. Steinman Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity Immunol. Rev. 220 2007 183 198 (Pubitemid 350045564)
17. S. Fujii, K. Shimizu, M. Kronenberg, and R.M. Steinman Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs Nat. Immunol. 3 2002 867 874
18. G. Giaccone, C.J. Punt, Y. Ando, R. Ruijter, N. Nishi, M. Peters, B.M. von Blomberg, R.J. Scheper, H.J. van der Vliet, and A.J. van den Eertwegh A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors Clin. Cancer Res. 8 2002 3702 3709 (Pubitemid 35424759)
19. D.I. Godfrey, and M. Kronenberg Going both ways: immune regulation via CD1d-dependent NKT cells J. Clin. Invest. 114 2004 1379 1388 (Pubitemid 40385565)
20. N. Hagenaars, E. Mastrobattista, H. Glansbeek, J. Heldens, H. van den Bosch, V. Schijns, D. Betbeder, H. Vromans, and W. Jiskoot Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model Vaccine 26 2008 6555 6563
21. Y. Hayakawa, D.I. Godfrey, and M.J. Smyth Alpha-galactosylceramide: potential immunomodulatory activity and future application Curr. Med. Chem. 11 2004 241 252 (Pubitemid 38128847)
22. R. Kaur, J. Chen, A. Dawoodji, V. Cerundolo, Y.R. Garcia-Diaz, J. Wojno, L.R. Cox, G.S. Besra, B. Moghaddam, and Y. Perrie Preparation, characterisation and entrapment of a non-glycosidic threitol ceramide into liposomes for presentation to invariant natural killer T cells J. Pharm. Sci. 100 2011 2724 2733
23. T. Kawano, J. Cui, Y. Koezuka, I. Toura, Y. Kaneko, K. Motoki, H. Ueno, R. Nakagawa, H. Sato, and E. Kondo CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides Science (New York, NY) 278 1997 1626 1629 (Pubitemid 27516282)
24. K.M. Kitchens, R.B. Kolhatkar, P.W. Swaan, N.D. Eddington, and H. Ghandehari Transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers: influence of size, charge and fluorescent labeling Pharm. Res. 23 2006 2818 2826 (Pubitemid 44885368)
25. Y.J. Kwon, E. James, N. Shastri, and J.M. Frechet In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles Proc. Natl. Acad. Sci. U.S.A. 102 2005 18264 18268 (Pubitemid 43011215)
26. C. Lamaze, and S.L. Schmid The emergence of clathrin-independent pinocytic pathways Curr. Opin. Cell Biol. 7 1995 573 580
27. R.U. Lemieux, K.B. Hendriks, R.V. Sticks, and K. James Halide ion catalysed glycosidation reactions syntheses of alpha-linked disaccharides J. Am. Chem. Soc. 97 1975 4056 4062
28. V. Manolova, A. Flace, M. Bauer, K. Schwarz, P. Saudan, and M.F. Bachmann Nanoparticles target distinct dendritic cell populations according to their size Eur. J. Immunol. 38 2008 1404 1413
29. J.L. Matsuda, L. Gapin, J.L. Baron, S. Sidobre, D.B. Stetson, M. Mohrs, R.M. Locksley, and M. Kronenberg Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo Proc. Natl. Acad. Sci. U.S.A. 100 2003 8395 8400 (Pubitemid 36842556)
30. S.K. Mendiratta, W.D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4 Immunity 6 1997 469 477 (Pubitemid 27208202)
31. J.W. Molling, W. Kolgen, H.J. van der Vliet, M.F. Boomsma, H. Kruizenga, C.H. Smorenburg, B.G. Molenkamp, J.A. Langendijk, C.R. Leemans, and B.M. von Blomberg Peripheral blood IFN-gamma-secreting Valpha24+Vbeta11+ NKT cell numbers are decreased in cancer patients independent of tumor type or tumor load Int. J. Cancer 116 2005 87 93 (Pubitemid 40827759)
32. J.W. Molling, M. Moreno, H.J. van der Vliet, A.J. van den Eertwegh, R.J. Scheper, B.M. von Blomberg, and H.J. Bontkes Invariant natural killer T cells and immunotherapy of cancer Clin. Immunol. (Orlando, FL) 129 2008 182 194
33. M. Morita, K. Motoki, K. Akimoto, T. Natori, T. Sakai, E. Sawa, K. Yamaji, Y. Koezuka, E. Kobayashi, and H. Fukushima Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice J. Med. Chem. 38 1995 2176 2187
34. S. Motohashi, S. Kobayashi, T. Ito, K.K. Magara, O. Mikuni, N. Kamada, T. Iizasa, T. Nakayama, T. Fujisawa, and M. Taniguchi Preserved IFN-alpha production of circulating Valpha24 NKT cells in primary lung cancer patients Int. J. Cancer 102 2002 159 165 (Pubitemid 35168029)
35. R.C. Mundargi, V.R. Babu, V. Rangaswamy, P. Patel, and T.M. Aminabhavi Nano/micro technologies for delivering poly(d,l-lactide-co-glycolide) and its derivatives J. Control. Release 125 2008 193 209
36. H.Y. Nam, S.M. Kwon, H. Chung, S.Y. Lee, S.H. Kwon, H. Jeon, Y. Kim, J.H. Park, J. Kim, and S. Her Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles J. Control. Release 135 2009 259 267
37. M. Nieda, M. Okai, A. Tazbirkova, H. Lin, A. Yamaura, K. Ide, R. Abraham, T. Juji, D.J. Macfarlane, and A.J. Nicol Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity Blood 103 2004 383 389 (Pubitemid 38140063)
38. P.B. O'Donnell, and J.W. McGinity Properties of multiphase microspheres of poly(dl-lactic acid) or poly(dl-lactic-co-glycolic acid) produced by mechanical agitation, sonication, or potentiometric dispersion J. Microencapsul. 13 1996 667 677 (Pubitemid 26385970)
39. C Paget, T. Mallevaey, A.O. Speak, D. Torres, J. Fontaine, K.C. Sheehan, M. Capron, B. Ryffel, C. Faveeuw, and M. Leite de Moraes Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids Immunity 27 2007 597 609 (Pubitemid 47628833)
40. V.V. Parekh, M.T. Wilson, D. Olivares-Villagomez, A.K. Singh, L. Wu, C.R. Wang, S. Joyce, and L. Van Kaer Glycolipid antigen induces long-term natural killer T cell anergy in mice J. Clin. Invest. 115 2005 2572 2583 (Pubitemid 41266220)
41. S.T. Reddy, A.J. van der Vlies, E. Simeoni, V. Angeli, G.J. Randolph, C.P. O'Neil, L.K. Lee, M.A. Swartz, and J.A. Hubbell Exploiting lymphatic transport and complement activation in nanoparticle vaccines Nat. Biotechnol. 25 2007 1159 1164 (Pubitemid 47538111)
42. J. Schmieg, G. Yang, R.W. Franck, N. Van Rooijen, and M. Tsuji Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion Proc. Natl. Acad. Sci. U.S.A. 102 2005 1127 1132 (Pubitemid 40170737)
43. B. Schneider, C. Schueller, O. Utermoehlen, and A. Haas Lipid microdomain-dependent macropinocytosis determines compartmentation of Afipia felis Traffic (Copenhagen, Denmark) 8 2007 226 240 (Pubitemid 46656514)
44. M. Singh, and D.T. O'Hagan Recent advances in vaccine adjuvants Pharm. Res. 19 2002 715 728 (Pubitemid 34686729)
45. N. Singh, S. Hong, D.C. Scherer, I. Serizawa, N. Burdin, M. Kronenberg, Y. Koezuka, and L. Van Kaer Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype J. Immunol. 163 1999 2373 2377 (Pubitemid 29399153)
46. P.J. Tacken, I.J. de Vries, R. Torensma, and C.G. Figdor Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting Nat. Rev. Immunol. 7 2007 790 802 (Pubitemid 47480309)
47. Y. Tamura, A. Teng, R. Nozawa, Y. Takamoto-Matsui, and Y. Ishii Characterization of the immature dendritic cells and cytotoxic cells both expanded after activation of invariant NKT cells with alpha-galactosylceramide in vivo Biochem. Biophys. Res. Commun. 369 2008 485 492
48. M. Taniguchi, M. Harada, S. Kojo, T. Nakayama, and H. Wakao The regulatory role of Valpha14 NKT cells in innate and acquired immune response Annu. Rev. Immunol. 21 2003 483 513 (Pubitemid 37174539)
49. M. Taniguchi, T. Tashiro, N. Dashtsoodol, N. Hongo, and H. Watarai The specialized iNKT cell system recognizes glycolipid antigens and bridges the innate and acquired immune systems with potential applications for cancer therapy Int. Immunol. 22 2010 1 6
50. T. Tatsumi, T. Takehara, S. Yamaguchi, A. Sasakawa, R. Sakamori, K. Ohkawa, K. Kohga, A. Uemura, and N. Hayashi Intrahepatic delivery of alpha-galactosylceramide-pulsed dendritic cells suppresses liver tumor Hepatology (Baltimore, MD) 45 2007 22 30 (Pubitemid 46144361)
51. P. Thapa, G. Zhang, C. Xia, A. Gelbard, W.W. Overwijk, C. Liu, P. Hwu, D.Z. Chang, A. Courtney, and J.K. Sastry Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy Vaccine 27 2009 3484 3488
52. I. Toura, T. Kawano, Y. Akutsu, T. Nakayama, T. Ochiai, and M. Taniguchi Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide J. Immunology 163 1999 2387 2391 (Pubitemid 29399156)
53. E. Tupin, Y. Kinjo, and M. Kronenberg The unique role of natural killer T cells in the response to microorganisms Nat. Rev. 5 2007 405 417 (Pubitemid 46780078)
54. H.J. van der Vliet, J.W. Molling, B.M. von Blomberg, N. Nishi, W. Kolgen, A.J. van den Eertwegh, H.M. Pinedo, G. Giaccone, and R.J. Scheper The immunoregulatory role of CD1d-restricted natural killer T cells in disease Clin. Immunol. (Orlando, FL) 112 2004 8 23 (Pubitemid 38781053)
55. L. Van Kaer, and S. Joyce Innate immunity: NKT cells in the spotlight Curr. Biol. 15 2005 R429 R431
56. M.M. Venkataswamy, and S.A. Porcelli Lipid and glycolipid antigens of CD1d-restricted natural killer T cells Semin. Immunol. 22 2010 68 78
57. L.H. Wang, K.G. Rothberg, and R.G. Anderson Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation J. Cell Biol. 123 1993 1107 1117 (Pubitemid 23352421)
58. M.T. Wilson, C. Johansson, D. Olivares-Villagomez, A.K. Singh, A.K. Stanic, C.R. Wang, S. Joyce, M.J. Wick, and L. Van Kaer The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion Proc. Natl. Acad. Sci. U.S.A. 100 2003 10913 10918 (Pubitemid 37140127)